A heat/cold modified fix Bethesda assay for detection of FIX inhibitors in the presence of residual FIX activity

被引:0
|
作者
Millner, A. [1 ]
Tiefenbacher, S. [2 ]
Robinson, M. [2 ]
Boesen, H. T. [1 ]
机构
[1] NOVO NORDISK, Cell & Antibody Anal, DMPK, Malov, Denmark
[2] Lab Corp America, Esoterix Coagulat, Denver, CO USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:28 / 29
页数:2
相关论文
共 19 条
  • [1] A variation of the Nijmegen-Bethesda assay using heat or a novel heat/cold pretreatment for the detection of FIX inhibitors in the presence of residual FIX activity
    Millner, A. H.
    Tiefenbacher, S.
    Robinson, M.
    Boesen, H. T.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 (06) : 639 - 647
  • [2] APTT reagents do not interfere with the heat/cold modified FIX Bethesda assay for detection of inhibitors in samples with pegylated FIX
    Millner, A.
    Boesen, H. T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 35 - 35
  • [3] DETECTION OF FVIII AND FIX INHIBITORS USING THROMBIN GENERATION ASSAY : A NEW DIAGNOSTIC APPROACH
    Van Even, Ellen
    Latinne, Dominique
    Lambert, Catherine
    Hermans, Cedric
    Eeckhoudt, Stephane
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2013, 35 : 16 - 16
  • [4] Comparison of fix activity of select novel recombinant fix replacement products in commonly used fda approved one-stage clot assay systems
    Robinson, M. M.
    Tiefenbacher, S.
    Ross, E. L.
    Williams, P. T.
    Cogswell, C. E.
    Wham, T. L.
    Adcock, D. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 325 - 325
  • [5] VISUAL INSPECTION OF THE APTT REACTION CURVE AS A RELIABLE SCREENING TOOL FOR DETECTING THE PRESENCE OF FVIII AND FIX INHIBITORS
    Pavic, J.
    Coen Herak, D.
    Milos, M.
    Zadro, R.
    HAEMATOLOGICA, 2019, 104 : 15 - 16
  • [6] Preliminary field study results suggest differences in FIX activity based on assay from gene therapy trial patients expressing R338L high-activity variant of FIX
    Pittman, Debra
    Carrieri, Charles
    Soares, Holly
    Mckay, John
    Tan, Charles
    Liang, John
    Rakhe, Swapnil
    Marshall, Jean-Claude
    Murphy, John
    Rupon, Jeremy
    HAEMOPHILIA, 2022, 28 : 45 - 46
  • [7] A simple screening method for the identification of the presence of FVIII and FIX inhibitors by determining the steepness of the routine aPTT reaction curves
    Herak, Coen D.
    Milos, M.
    Zadro, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 964 - 964
  • [8] Activity of a FIX-Padua Transgene Product in Commonly Used FIX:C One-Stage and Chromogenic Assay Systems Following PF-06838435 (SPK-9001) Gene Delivery
    Robinson, Mary
    George, Lindsey A.
    Samelson-Jones, Benjamin J.
    Arruda, Valder R.
    High, Katherine A.
    Carr, Marcus E.
    Tiefenbacher, Stefan
    BLOOD, 2018, 132
  • [9] Incidence of inhibitors against FVIII or FIX in PTPs after switching factor concentrate during the presence of immunological danger signals
    Kocher, S.
    Asmelash, G.
    Makki, V.
    Mueller, S.
    Krekeler, S.
    Alesci, S.
    Miesbach, W.
    HAEMOPHILIA, 2012, 18 : 91 - 92
  • [10] IMPACT OF FIX ACTIVITY ASSAY RESULTS DETERMINED WITH ONE-STAGE CLOTTING AND CHROMOGENIC ASSAYS ON THE CLASSIFICATION OF HAEMOPHILIA B
    Pavic, J.
    Milos, M.
    Herak, Coen D.
    Juros, Fressl G.
    Boban, A.
    Bilic, E.
    Salek, Zupancic S.
    Zadro, R.
    HAEMOPHILIA, 2023, 29 : 20 - 20